glp 1 and gip receptor agonist GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica GLP-1 Receptor Agonists Explained for

Semaglutide: Tirzepatide is a dual agonist for GLP-1 and GIP receptors

Incorporating this botanical product into a balanced diet supports healthy metabolism as well as regular digestive and muscle function without risking undernutrition.*

Switching to the oral small molecule glucagon-like peptide-1 (GLP-1) orforglipron after taking injectable GLP-1s helped patients maintain mostbut not allof their weight loss, according to a clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

See if you qualify

Gastrointestinal (GI) adverse eventsparticularly nausea, vomiting, diarrhea, and constipationare the most common side effects, generally emerging during dose escalation and resolving over time